Skip to main content

Inproteo Licenses Protein Purification Technique to ZymoGenetics

NEW YORK, Jan. 9 (GenomeWeb News) - Inproteo said today it has licensed a patent for a protein purification technique to ZymoGenetics.


ZymoGenetics' license to the so-called Smith patent, which protects the His tag fusion protein purification technique, covers all uses of the technology for the life of the patent.


Inproteo, formerly known as the Indiana Proteomics Consortium - a partnership between Indiana University, Purdue University, and Eli Lilly - recently obtained a license to the patent, U.S. Patent No. 4,569,794, from Eli Lilly. It holds the exclusive right to sublicense the patent and has already licensed it to a number of companies.


The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.